Literature DB >> 27396632

Pancreatic cancer: cause for optimism?

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27396632     DOI： 10.1016/S1470-2045(16)30234-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Individualized drug screening based on next generation sequencing and patient derived xenograft model for pancreatic cancer with bone metastasis.

Authors:  Zhonghai Guan; Huanrong Lan; Xiangheng Chen; Xiaoxia Jiang; Xuanwei Wang; Ketao Jin
Journal:  Mol Med Rep       Date:  2017-08-10       Impact factor: 2.952

2.  EIF5A regulates proliferation and chemoresistance in pancreatic cancer through the sHH signalling pathway.

Authors:  Zheng Wang; Jie Jiang; Tao Qin; Ying Xiao; Liang Han
Journal:  J Cell Mol Med       Date:  2019-02-14       Impact factor: 5.310

3.  A potential novel therapy for FGFR1-amplified pancreatic cancer with bone metastasis, screened by next-generation sequencing and a patient-derived xenograft model.

Authors:  Zhonghai Guan; Huanrong Lan; Dan Sun; Xuanwei Wang; Ketao Jin
Journal:  Oncol Lett       Date:  2018-12-28       Impact factor: 2.967
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.